Botulinum toxin type A for the treatment of muscle contractures secondary to acute spinal cord injury in a young cat

Case summary A 4-month-old male entire domestic shorthair cat presented for sudden onset of right thoracic monoparesis following a fall; within 18 h, the clinical signs progressed to non-ambulatory right hemiplegia with absent sensation in the distal right thoracic limb and left hemiparesis. MRI rev...

Full description

Bibliographic Details
Main Authors: Robert I McGeachan, Tobias Schwarz, Danièlle A Gunn-Moore, Katia Marioni-Henry
Format: Article
Language:English
Published: SAGE Publishing 2020-05-01
Series:Journal of Feline Medicine and Surgery Open Reports
Online Access:https://doi.org/10.1177/2055116920922648
id doaj-7667c94ad63b4d25b0e8afbf58e87680
record_format Article
spelling doaj-7667c94ad63b4d25b0e8afbf58e876802020-11-25T03:36:02ZengSAGE PublishingJournal of Feline Medicine and Surgery Open Reports2055-11692020-05-01610.1177/2055116920922648Botulinum toxin type A for the treatment of muscle contractures secondary to acute spinal cord injury in a young catRobert I McGeachanTobias SchwarzDanièlle A Gunn-MooreKatia Marioni-HenryCase summary A 4-month-old male entire domestic shorthair cat presented for sudden onset of right thoracic monoparesis following a fall; within 18 h, the clinical signs progressed to non-ambulatory right hemiplegia with absent sensation in the distal right thoracic limb and left hemiparesis. MRI revealed changes consistent with a C6–C7 acute non-compressive nucleus pulposus extrusion with suspected secondary C5–C7 spinal cord haemorrhage. Rehabilitation exercises were started immediately after the diagnosis of acute spinal cord trauma. Sensation in the right thoracic limb improved and, with the help of a splint applied to that limb, the cat was ambulatory on all four limbs. Unfortunately, clinical signs started to progress over the course of 10 days. The cat developed progressive discomfort on manipulation of the right elbow and carpus, and a hyperflexion of the right carpus. Radiographs revealed no skeletal abnormalities. Muscle contractures were suspected. Under general anaesthesia the triceps and flexor muscles of the carpus and digits were injected with a total of 100 U of botulinum toxin type A (BTX-A). No complications were associated with the procedure and 24 h after the injection the carpal hyperflexion resolved. Relevance and novel information The use of BTX-A to treat muscle contractures in human medicine is an established and increasingly used technique. For example, in subacute stroke patients with a non-functional arm, BTX-A forearm injection appears to prevent disabling finger stiffness, likely by minimising the development of contractures. Here, we demonstrate that intramuscular BTX-A is an effective treatment for acquired muscle contractures in a cat.https://doi.org/10.1177/2055116920922648
collection DOAJ
language English
format Article
sources DOAJ
author Robert I McGeachan
Tobias Schwarz
Danièlle A Gunn-Moore
Katia Marioni-Henry
spellingShingle Robert I McGeachan
Tobias Schwarz
Danièlle A Gunn-Moore
Katia Marioni-Henry
Botulinum toxin type A for the treatment of muscle contractures secondary to acute spinal cord injury in a young cat
Journal of Feline Medicine and Surgery Open Reports
author_facet Robert I McGeachan
Tobias Schwarz
Danièlle A Gunn-Moore
Katia Marioni-Henry
author_sort Robert I McGeachan
title Botulinum toxin type A for the treatment of muscle contractures secondary to acute spinal cord injury in a young cat
title_short Botulinum toxin type A for the treatment of muscle contractures secondary to acute spinal cord injury in a young cat
title_full Botulinum toxin type A for the treatment of muscle contractures secondary to acute spinal cord injury in a young cat
title_fullStr Botulinum toxin type A for the treatment of muscle contractures secondary to acute spinal cord injury in a young cat
title_full_unstemmed Botulinum toxin type A for the treatment of muscle contractures secondary to acute spinal cord injury in a young cat
title_sort botulinum toxin type a for the treatment of muscle contractures secondary to acute spinal cord injury in a young cat
publisher SAGE Publishing
series Journal of Feline Medicine and Surgery Open Reports
issn 2055-1169
publishDate 2020-05-01
description Case summary A 4-month-old male entire domestic shorthair cat presented for sudden onset of right thoracic monoparesis following a fall; within 18 h, the clinical signs progressed to non-ambulatory right hemiplegia with absent sensation in the distal right thoracic limb and left hemiparesis. MRI revealed changes consistent with a C6–C7 acute non-compressive nucleus pulposus extrusion with suspected secondary C5–C7 spinal cord haemorrhage. Rehabilitation exercises were started immediately after the diagnosis of acute spinal cord trauma. Sensation in the right thoracic limb improved and, with the help of a splint applied to that limb, the cat was ambulatory on all four limbs. Unfortunately, clinical signs started to progress over the course of 10 days. The cat developed progressive discomfort on manipulation of the right elbow and carpus, and a hyperflexion of the right carpus. Radiographs revealed no skeletal abnormalities. Muscle contractures were suspected. Under general anaesthesia the triceps and flexor muscles of the carpus and digits were injected with a total of 100 U of botulinum toxin type A (BTX-A). No complications were associated with the procedure and 24 h after the injection the carpal hyperflexion resolved. Relevance and novel information The use of BTX-A to treat muscle contractures in human medicine is an established and increasingly used technique. For example, in subacute stroke patients with a non-functional arm, BTX-A forearm injection appears to prevent disabling finger stiffness, likely by minimising the development of contractures. Here, we demonstrate that intramuscular BTX-A is an effective treatment for acquired muscle contractures in a cat.
url https://doi.org/10.1177/2055116920922648
work_keys_str_mv AT robertimcgeachan botulinumtoxintypeaforthetreatmentofmusclecontracturessecondarytoacutespinalcordinjuryinayoungcat
AT tobiasschwarz botulinumtoxintypeaforthetreatmentofmusclecontracturessecondarytoacutespinalcordinjuryinayoungcat
AT danielleagunnmoore botulinumtoxintypeaforthetreatmentofmusclecontracturessecondarytoacutespinalcordinjuryinayoungcat
AT katiamarionihenry botulinumtoxintypeaforthetreatmentofmusclecontracturessecondarytoacutespinalcordinjuryinayoungcat
_version_ 1724551662038679552